Menu
Celldex Therapeutics   

Research and development, Research and experimental development on natural sciences and engineering....

Celldex Announces Acquisition of Assets of Alteris Therapeutics, Inc.   

October 12, 2005 - Philadelphia, PA - Celldex Therapeutics, Inc. today announced that it has acquired substantially all assets of Alteris Therapeutics, ......

Celldex Therapeutics Announces Orphan Drug Designation For CDX-110 ...   

Клинические испытания в Украине. Clinical Trials in Ukraine. Celldex Therapeutics Announces Orphan Drug Designation For CDX-110, A Novel EGFRvIII Vaccine ......

StreetInsider.com - Celldex Announces FDA Orphan Drug Designation ...   

Dec 7, 2007 ... Celldex Therapeutics announced today that the FDA has granted orphan drug designation for Celldex's CDX-110 for the treatment of EGFRvIII ......

CheckOrphan Celldex Therapeutics receives designation for CDX-110 ...   

Celldex Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Celldex's CDX-110 for the treatment of ......

Don Drakeman, Celldex Therapeutics, Bloomsbury, NJ in Spoke's ...   

Don Drakeman's email, business address and phone, bio, title, job history, colleagues, and other professional information listed in Spoke's business ......

www. celldex .biz - Under Construction   

Welcome to www. celldex .biz. This website was registered at Misk.com. Come register your domain name today!...

Mass High Tech: The Journal of New England Technology: Celldex ...   

May 14, 2008 ... American City Business Journals Inc. is the nation's largest publisher of metropolitan business newspapers, serving 41 of the country's most ......

Celldex Announces Acquisition of Lorantis Limited and Assets of ...   

Today Celldex Therapeutics, Inc. announced its acquisition of Lorantis Limited, a privately held biotechnology company based in Cambridge, U.K., ......

Avant, Celldex to merge - Daily Business Update - The Boston Globe   

Oct 22, 2007 ... Needham biotechnology company Avant Immunotherapeutics Inc. said today that it will merge with privately owned Celldex Therapeutics Inc.. ......

Avant Immunotherapeutics News - Pharmaceutical Industry Today   

Sampson consults for the vaccine's maker, Celldex Therapeutics, a subsidiary of Avant Immunotherapeutics, and gets licensing fees from the vaccine. ......

AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc ...   

Oct. 22, 2007 (Voxant delivered by Newstex) -- OPERATOR: Good morning and welcome to the AVANT/ Celldex merger announcement conference call....

AVANT ANNOUNCES COMPLETED MERGER WITH CELLDEX AND 1-FOR-12 REVERSE ...   

Approximately 104.8 million shares (on a pre-split basis) are being issued to the former Celldex shareholders in connection with the merger, having a value ......

Yahoo! Message Boards - AVANT Immunotherapeutics, Inc. - Senator ...   

View all Topics | View all Messages < Newer Topic | Older Topic >. Re: Senator Kennedy and Celldex 10-Jun-08 10:05 am ......

SEC Info - Celldex Therapeutics Inc - S-1 - On 4/8/04 - EX-2.1   

Celldex Therapeutics Inc - S-1 - On 4/8/04 - EX-2.1 - Registration Statement (General Form) - Seq. 2 - Plan of Acquisition, Reorganization, Arrangement, ......

1   2   3   4   5   next   last